» Articles » PMID: 34603778

The Diverse Roles of TMEM16A Ca-activated Cl Channels in Inflammation

Overview
Journal J Adv Res
Date 2021 Oct 4
PMID 34603778
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Transmembrane protein 16A (TMEM16A) Ca-activated Cl channels have diverse physiological functions, such as epithelial secretion of Cl and fluid and sensation of pain. Recent studies have demonstrated that TMEM16A contributes to the pathogenesis of infectious and non-infectious inflammatory diseases. However, the role of TMEM16A in inflammation has not been clearly elucidated.

Aim Of Review: In this review, we aimed to provide comprehensive information regarding the roles of TMEM16A in inflammation by summarizing the mechanisms underlying TMEM16A expression and activation under inflammatory conditions, in addition to exploring the diverse inflammatory signaling pathways activated by TMEM16A. This review attempts to develop the idea that TMEM16A plays a diverse role in inflammatory processes and contributes to inflammatory diseases in a cellular environment-dependent manner.

Key Scientific Concepts Of Review: Multiple inflammatory mediators, including cytokines (e.g., interleukin (IL)-4, IL-13, IL-6), histamine, bradykinin, and ATP/UTP, as well as bacterial and viral infections, promote TMEM16A expression and/or activity under inflammatory conditions. In addition, TMEM16A activates diverse inflammatory signaling pathways, including the IPR-mediated Ca signaling pathway, the NF-κB signaling pathway, and the ERK signaling pathway, and contributes to the pathogenesis of many inflammatory diseases. These diseases include airway inflammatory diseases, lipopolysaccharide-induced intestinal epithelial barrier dysfunction, acute pancreatitis, and steatohepatitis. TMEM16A also plays multiple roles in inflammatory processes by increasing vascular permeability and leukocyte adhesion, promoting inflammatory cytokine release, and sensing inflammation-induced pain. Furthermore, TMEM16A plays its diverse pathological roles in different inflammatory diseases depending on the disease severity, proliferating status of the cells, and its interacting partners. We herein propose cellular environment-dependent mechanisms that explain the diverse roles of TMEM16A in inflammation.

Citing Articles

DTIAM: a unified framework for predicting drug-target interactions, binding affinities and drug mechanisms.

Lu Z, Song G, Zhu H, Lei C, Sun X, Wang K Nat Commun. 2025; 16(1):2548.

PMID: 40089473 DOI: 10.1038/s41467-025-57828-0.


Revealing the antimicrobial potential of traditional Chinese medicine through text mining and molecular computation.

Chung M, Su L, Chen C, Wu L Brief Bioinform. 2025; 26(1).

PMID: 40007160 PMC: 11859959. DOI: 10.1093/bib/bbaf077.


The signature of the gut microbiota associated with psoriatic arthritis revealed by metagenomics.

Liu W, Li C, Xie W, Fan Y, Zhang X, Wang Y Ther Adv Musculoskelet Dis. 2024; 16:1759720X241266720.

PMID: 39131798 PMC: 11316960. DOI: 10.1177/1759720X241266720.


TMEM16 proteins: Ca‑activated chloride channels and phospholipid scramblases as potential drug targets (Review).

Huang Z, Iqbal Z, Zhao Z, Chen X, Mahmmod A, Liu J Int J Mol Med. 2024; 54(4).

PMID: 39092585 PMC: 11315658. DOI: 10.3892/ijmm.2024.5405.


Niclosamide potentiates TMEM16A and induces vasoconstriction.

Liang P, Wan Y, Yu K, Hartzell H, Yang H J Gen Physiol. 2024; 156(7).

PMID: 38814250 PMC: 11138202. DOI: 10.1085/jgp.202313460.


References
1.
Zhang M, Gao C, Wang Y, Ma K, Li L, Yin J . The association between the expression of PAR2 and TMEM16A and neuropathic pain. Mol Med Rep. 2017; 17(3):3744-3750. PMC: 5802179. DOI: 10.3892/mmr.2017.8295. View

2.
Vallath S, Hynds R, Succony L, Janes S, Giangreco A . Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities. Eur Respir J. 2014; 44(2):513-22. PMC: 4209854. DOI: 10.1183/09031936.00146413. View

3.
Deba F, Bessac B . Anoctamin-1 Cl(-) channels in nociception: activation by an N-aroylaminothiazole and capsaicin and inhibition by T16A[inh]-A01. Mol Pain. 2015; 11:55. PMC: 4567824. DOI: 10.1186/s12990-015-0061-y. View

4.
Dai W, Qiu J, Sun J, Ma C, Huang N, Jiang Y . Downregulation of microRNA-9 reduces inflammatory response and fibroblast proliferation in mice with idiopathic pulmonary fibrosis through the ANO1-mediated TGF-β-Smad3 pathway. J Cell Physiol. 2018; 234(3):2552-2565. DOI: 10.1002/jcp.26961. View

5.
Kondo M, Tsuji M, Hara K, Arimura K, Yagi O, Tagaya E . Chloride ion transport and overexpression of TMEM16A in a guinea-pig asthma model. Clin Exp Allergy. 2017; 47(6):795-804. DOI: 10.1111/cea.12887. View